CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Olio Labs releases study showcasing AI-driven in vivo platform can predict clinical trial outcomes

Positive
AI Analysis

Summary

Olio Labs published research demonstrating its AI-driven preclinical in vivo platform can predict human clinical trial outcomes including gastrointestinal adverse events and cardiac toxicity.

Importance:4/10
Sentiment:
0.60
AI platformpreclinicalin vivoclinical trial predictiontoxicity assessment

Read the original article

Published by PR Newswire Biotech on August 5, 2026 6:40 PM

Read Original